We are live on ! Find out more
OAM

Oppenheimer Asset Management Portfolio holdings

AUM $9.63B
1-Year Est. Return 30.32%
This Fund
S&P 500
This Quarter Est. Return
+7.72%
1 Year Est. Return
+30.32%
3 Year Est. Return
+85%
5 Year Est. Return
+99.62%
10 Year Est. Return
+601.29%
AUM
$7.02B
AUM Growth
+$570M
Cap. Flow
+$123M
Cap. Flow %
1.75%
Top 10 Hldgs %
15.06%
Holding
1,247
New
85
Increased
719
Reduced
392
Closed
47

Top Buys

Rank Stock Value
1
LBTYK icon
Liberty Global Class C
LBTYK
+$10.2M
2
VICI icon
VICI Properties
VICI
+$8.36M
3
ALL icon
Allstate
ALL
+$7.41M
4
UTHR icon
United Therapeutics
UTHR
+$6.59M
5
MMS icon
Maximus
MMS
+$5.9M

Sector Composition

Rank Sector Weight
1 Technology 20.61%
2 Healthcare 13.94%
3 Financials 13.92%
4 Consumer Discretionary 10.22%
5 Industrials 8.62%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DIS icon
51
Walt Disney
DIS
$181B
$29.5M 0.42%
167,765
+713
+0.4% +$128K
TGT icon
52
Target
TGT
$68B
$28.8M 0.41%
119,080
-7,848
-6% -$1.72M
MRK icon
53
Merck
MRK
$318B
$28.1M 0.4%
361,090
+26,886
+8% +$2M
VEEV icon
54
Veeva Systems
VEEV
$37.4B
$27.7M 0.39%
89,024
+2,867
+3% +$799K
VZ icon
55
Verizon
VZ
$196B
$27.6M 0.39%
492,941
+9,205
+2% +$528K
MMM icon
56
3M
MMM
$94.3B
$27.6M 0.39%
166,207
+5,046
+3% +$842K
NEE icon
57
NextEra Energy
NEE
$177B
$26.6M 0.38%
362,562
-3,802
-1% -$285K
TFC icon
58
Truist Financial
TFC
$64B
$25.6M 0.37%
462,034
+3,038
+0.7% +$178K
NVO
59
Novo Nordisk
NVO
$209B
$25M 0.36%
595,916
+132
+0% +$5.12K
GD icon
60
General Dynamics
GD
$106B
$24.4M 0.35%
129,624
+4,054
+3% +$764K
GPC icon
61
Genuine Parts
GPC
$18.7B
$24.2M 0.35%
191,571
+4,551
+2% +$573K
JCI icon
62
Johnson Controls International
JCI
$92.2B
$24M 0.34%
349,547
-9,288
-3% -$599K
ISRG icon
63
Intuitive Surgical
ISRG
$134B
$23.7M 0.34%
77,238
+1,989
+3% +$558K
FLOW
64
DELISTED
SPX FLOW, Inc.
FLOW
$23.1M 0.33%
354,550
-58
-0% -$3.87K
INFO
65
DELISTED
IHS Markit Ltd. Common Shares
INFO
$22.3M 0.32%
198,194
-8,216
-4% -$872K
BCE icon
66
BCE
BCE
$21.2B
$22.2M 0.32%
450,265
+20,241
+5% +$980K
ORCL icon
67
Oracle
ORCL
$423B
$22.2M 0.32%
285,302
+9,994
+4% +$782K
BMY icon
68
Bristol-Myers Squibb
BMY
$132B
$21.7M 0.31%
325,375
+64,550
+25% +$4.21M
ALGN icon
69
Align Technology
ALGN
$12.3B
$21.6M 0.31%
35,345
+970
+3% +$574K
FIVE icon
70
Five Below
FIVE
$13.5B
$21.4M 0.31%
110,807
+3,481
+3% +$665K
WFC icon
71
Wells Fargo
WFC
$264B
$21.4M 0.3%
471,859
+4,401
+0.9% +$197K
DHR icon
72
Danaher
DHR
$144B
$21.3M 0.3%
89,399
-826
-0.9% -$183K
TSM icon
73
TSMC
TSM
$2.18T
$21.3M 0.3%
176,908
+3,675
+2% +$431K
AMT icon
74
American Tower
AMT
$80.4B
$21M 0.3%
77,912
+10,205
+15% +$2.6M
ILMN icon
75
Illumina
ILMN
$28.4B
$21M 0.3%
45,669
+811
+2% +$327K

Similar funds

Oppenheimer Asset Management's Q2 2021 Portfolio in Review

As of Q2 2021, Oppenheimer Asset Management held 1,247 positions worth $7.02B, up 8.8% from $6.45B the previous quarter. Its ten largest holdings account for 15% of the portfolio.

Oppenheimer Asset Management's Q2 2021 filing shows 85 new, 719 increased, 392 reduced and 47 closed positions. Its largest new stake was United Therapeutics: 34,595 shares worth $6.21M. The largest sale was Affiliated Managers Group, an estimated $24.7M.

By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 20% a quarter earlier, followed by Healthcare and Financials.

  • Oppenheimer Asset Management's largest Q2 2021 buy was United Therapeutics: 34,595 shares worth $6.21M.
  • Oppenheimer Asset Management added most to Liberty Global Class C in Q2 2021, an estimated $10.2M increase.
  • Oppenheimer Asset Management's biggest Q2 2021 reduction was Affiliated Managers Group, cutting an estimated $24.7M.
  • Oppenheimer Asset Management fully exited Varian Medical Systems, Inc. in Q2 2021, selling an estimated $5.92M.
  • Oppenheimer Asset Management's ten largest holdings make up 15% of its $7.02B portfolio in Q2 2021.
  • Oppenheimer Asset Management opened 85 new positions and closed 47 in Q2 2021.
  • Oppenheimer Asset Management's portfolio value rose 8.8% quarter-over-quarter to $7.02B.

Based on Oppenheimer Asset Management's 13F filing for Q2 2021, filed 3 Aug 2021.